EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells

Preenapan Changphasuk, Chaturong Inpad, Sukanya Horpaopan, Sasiprapa Khunchai, Suchada Phimsen, Damratsamon Surangkul, Tavan Janvilisri, Atit Silsirivanit, Worasak Kaewkong

Frontiers in Bioscience-Scholar · 29.09.2024 · 16 (3)

DOI: 10.31083/j.fbs1603017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Scholar, online erschienen am 29.09.2024. Verfasst von Preenapan Changphasuk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medical Science, Naresuan University, 65000 Phitsanulok, Thailand. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Apoptosis, Serine-Arginine Splicing Factors, Bile Duct Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, NRCT-Research Career Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cholangiocarcinoma (CCA) is a malignancy of the bile duct epithelium that is commonly found in the Thai population. CCA has poor prognosis and a low survival rate due to the lack of early diagnosis methods and the limited effectiveness of current treatments. A number of oncogenic spliced-transcripts resulting from mRNA splicing errors have been reported in CCA, and aberrant mRNA splicing is suspected to be a key driver of this cancer type. The hyperphosphorylation of serine/arginine rich-splicing factors (SRSFs) by serine/arginine protein kinases (SRPKs) causes them to translocate to the nucleus where they facilitate gene splicing errors that generate cancer-related mRNA/protein isoforms.

Methods

The correlation between SRPK expression and the survival of CCA patients was analyzed using data from The Cancer Genome Atlas (TCGA) dataset. The effect of SRPK inhibitors (SRPIN340 and SPHINX31) on two CCA cell lines (KKU-213A and TFK-1) was also investigated. The induction of cell death was studied by Calcein-AM/PI staining, AnnexinV/7AAD staining, immunofluorescence (IF), and Western blotting (WB). The phosphorylation and nuclear translocation of SRSFs was tracked by WB and IF, and the repair of splicing errors was examined by Reverse Transcription-Polymerase Chain Reaction (RT-PCR).

Results

High levels of SRPK1 and SRPK2 transcripts, and in particular SRPK1, correlated with shorter survival in CCA patients. SRPIN340 and SPHINX31 increased the number of dead and apoptotic cells in a dose-dependent manner. CCA also showed diffuse expression of cytoplasmic cytochrome C and upregulation of cleaved caspase-3. Moreover, SRSFs showed low levels of phosphorylation, resulting in the accumulation of cytoplasmic SRSF1. To link these phenotypes with aberrant gene splicing, the apoptosis-associated genes Bridging Integrator 1 (BIN1), Myeloid cell leukemia factor 1 (MCL-1) and B-cell lymphoma 2 (BCL2) were selected for further investigation. Treatment with SRPIN340 and SPHINX31 decreased anti-apoptotic BIN1+12A and increased pro-apoptotic MCL-1S and BCL-xS.

Conclusions

The SRPK inhibitors SRPIN340 and SPHINX31 can suppress the phosphorylation of SRSFs and their nuclear translocation, thereby producing BIN1, MCL-1 and BCL2 isoforms that favor apoptosis and facilitate CCA cell death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaApoptosisSerine-Arginine Splicing FactorsBile Duct NeoplasmsMyeloid Cell Leukemia Sequence 1 ProteinProtein Serine-Threonine KinasesProto-Oncogene Proteins c-bcl-2HumansPhosphorylationCell Line, TumorAdaptor Proteins, Signal TransducingRNA SplicingTumor Suppressor ProteinsNuclear ProteinsProtein Kinase Inhibitors

Stichwörter der Autor:innen

SRPKSRSFalternative splicingapoptosischolangiocarcinoma

Substanzen

Serine-Arginine Splicing FactorsMCL1 protein, humanMyeloid Cell Leukemia Sequence 1 ProteinProtein Serine-Threonine KinasesProto-Oncogene Proteins c-bcl-2SRPK1 protein, humanAdaptor Proteins, Signal TransducingBCL2 protein, humanTumor Suppressor ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medical Science, Naresuan University, 65000 Phitsanulok, Thailand.
  • Department of Anatomy, Faculty of Medicine, Chiang Mai University, 50200 Chiang Mai, Thailand.
  • Department of Anatomy, Faculty of Medical Science, Naresuan University, 65000 Phitsanulok, Thailand.
  • Department of Biochemistry, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand.
  • Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 4002 Khon Kaen, Thailand.

Förderung

  • National Research Council of Thailand, NRCT-Research Career Development

Zitieren

APA

Changphasuk, P., Inpad, C., Horpaopan, S., Khunchai, S., Phimsen, S., Surangkul, D., Janvilisri, T., Silsirivanit, A., & Kaewkong, W. (2024). SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells. Frontiers in Bioscience-Scholar, 16(3). https://doi.org/10.31083/j.fbs1603017

Vancouver

Changphasuk P, Inpad C, Horpaopan S, Khunchai S, Phimsen S, Surangkul D, et al. SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells. Frontiers in Bioscience-Scholar. 2024;16(3). doi:10.31083/j.fbs1603017

BibTeX
@article{Changphasuk2024,
  author = {Changphasuk, Preenapan and Inpad, Chaturong and Horpaopan, Sukanya and Khunchai, Sasiprapa and Phimsen, Suchada and Surangkul, Damratsamon and Janvilisri, Tavan and Silsirivanit, Atit and Kaewkong, Worasak},
  title = {SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells},
  journal = {Frontiers in Bioscience-Scholar},
  year = {2024},
  volume = {16},
  number = {3},
  doi = {10.31083/j.fbs1603017}
}
Kostenlos starten →